Skip to main content

Table 1 Baseline characteristics and dietary intake of various Apolipoprotein B gene polymorphisms in patients with type 2 diabetes

From: Deletion allele of Apo B gene is associated with higher inflammation, oxidative stress and dyslipidemia in obese type 2 diabetic patients: an analytical cross-sectional study

Variable

Patients

Non-obese

n = 90

Obese

n = 72

Total

n = 162

Polymorphisms

Ins/Ins

n = 60

Del carrier

n = 30

Ins/Ins

n = 47

Del carrier

n = 25

Ins/Ins

n = 107

Del carrier

n = 55

Age, year

54.77 ± 6.25

55.73 ± 5.33

53.13 ± 6.91

52.92 ± 7.18

54.05 ± 6.57

54.45 ± 6.34

BMI, kg/m2

26.22 ± 2.26

26.21 ± 2.44

33.1 ± 3.57

33.29 ± 3.33

29.23 ± 4.48

29.43 ± 4.56

Waist circumference, cm

86.92 ± 7.76

84.79 ± 9.02

100.34 ± 9.34

95.74 ± 9.94

92.81 ± 10.77

89.86 ± 10.87

Physical activity, time/day

39.64 ± 6.4

38.42 ± 5.3

37.55 ± 5.46

37.48 ± 3.69

38.72 ± 6.07

37.99 ± 4.62

Sex

  Male

27 (45)

10(33.3)

14 (29.8)

8 (32)

41(38.3)

18 (32.7)

  Female

33 (55)

20 (66.7)

33 (70.2)

17(68)

66 (61.7)

37(67.3)

Dietary intake

      

  Energy, kcal/day

2572 ± 905

2680 ± 1677

2374 ± 702

2737 ± 1141

2485 ± 824

2706 ± 1445

  Carbohydrate, g/day

352.97 ± 6.92

367.92 ± 9.79

318.42 ± 11

346.47 ± 15.1

338.22 ± 6.20

357.35 ± 8.66

  Protein, g/day

90.52 ± 2.3

96.98 ± 3.26

85.39 ± 2.25

83.02 ± 3.11

88.61 ± 1.73

89.97 ± 2.42

  Fat, g/day

101.09 ± 3.48

92.29 ± 4.92

106.52 ± 4.29

96.8 ± 5.92

103 ± 2.79

95.3 ± 3.89

  PUFA, g/day

23.51 ± 1.29

21.68 ± 1.73

27.47 ± 1.53

22.97 ± 2.12

25.08 ± 1.02

22.6 ± 1.43

  MUFA, g/day

32.8 ± 1.34

31.64 ± 1.89

38.03 ± 1.83

32.44 ± 2.52

34.88 ± 1.14

32.37 ± 1.6

  SFA, g/day

26.51 ± 0.86

26.73 ± 1.22

27.28 ± 1.2

25.63 ± 1.66

26.76 ± 25.34

26.4 ± 1

  Fiber, g/day

42.82 ± 20.65

48.95 ± 13.5

36.77 ± 15.3

42.86 ± 19.5

40.16 ± 18.7

46.18 ± 39.7

Intake of lipid lowering drugs

      

  Yes

29(48.3)

20 (66.7)

20 (42.6)

15 (60)

49 (45.8)

35 (63.6)

  No

31(51.7)

10(33.3)

27 (57.4)

10 (40)

58 (54.2)

20 (36.4)

Intake of antidiabetic drugs

   

  Yes

54 (90)

27 (90)

44 (93.6)

24 (96)

98 (91.6)

51 (92.7)

  No

6 (10)

3 (10)

3 (6.4)

1 (24)

9 (8.4)

4 (7.3)

  1. Significant difference in the obese population using the independent t-test (p<0.05)
  2. Significant difference in total population using the chi-square test (p<0.05)
  3. BMI body mass index, PUFA poly unsaturated fatty acid, MUFA mono unsaturated fatty acid, SFA saturated fatty acids